Details of the Drug
General Information of Drug (ID: DMLEUUS)
| Drug Name |
HBF-0259
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms | PBHBV-001; PBHBV-2-1; PBHBV-2-15; Hepatitis B surface antigen inhibitors (oral, hepatitis B virus infection), Institute for Hepatitis & Virus Research/Enantigen Therapeutics | ||||||||||||||||||
| Indication |
|
||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||

